Cyberattack Alert - Severe WARNINGS & CAUTIONS to All Members
NASDAQ  7,003.74 -3.61 (-0.05%)
DJIA  24,083.83 59.70 (+0.24%)
S&P 500  2,639.40 4.84 (+0.18%)
25/04/2018 16:04

FDA


Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions

26/04/2018 00:56

SAN DIEGO , April 25, 2018 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) to...

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

25/04/2018 22:30

WESTLAKE VILLAGE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:M...

Rigel Pharmaceuticals Is In Bargain Territory

25/04/2018 21:47

Source: Pixabay I normally avoid companies that are likely to issue a secondary or have ...

Flex Pharma to Report First Quarter 2018 Financial Results on May 2, 2018

25/04/2018 21:19

Flex Pharma, Inc . (NASDAQ: FLKS), a clinical-stage biotechnology company that is developin...

Acadia down 20% on FDA relook at Nuplazid safety data

25/04/2018 21:16

Acadia Pharmaceuticals ( ACAD -19.6% ) slumps on more than a 5x surge in volume on the hee...

AKRX EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 7, 2018

25/04/2018 21:15

NEW YORK, NY / ACCESSWIRE / April 25, 2018 / The Law Offices of Vincent Wong announce that a...

Page of 625

Terms and Conditions | Privacy Statement
Financial.org is an educational platform. We DO NOT deal with securities and receive any financial benefits from Financial Products & Service Providers.